Bayer Investor Relations

A bird's eye view of a building with a logo on it.
Investor News
July 17, 2024
Not intended for U.S. and UK Media
Darolutamide meets primary endpoint in Phase III ARANOTE trial in men with metastatic hormone-sensitive prostate cancer
July 11, 2024
Not intended for UK Media
AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson’s disease
June 17, 2024
Crop Science Innovation Update 2024:
Bayer to deliver ten blockbusters in ten years